Speaker illustration

Professor Jindrich Spinar

St. Anne University Hospital Brno (FNUSA), Brno (Czechia)

Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

Event: ESC Congress 2019

Topic: Comorbidities

Session: Heart failure treatment, HFpEF, HFmrEF

Thumbnail

Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction, a report from FAR NHL registry

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

FAR NHL FARmacology and NeuroHumoraL activation in chronic heart failure - one year prognosis

Event: Heart Failure 2018

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Thumbnail

Epidemiology in Czech Republic

Event: Heart Failure 2018

Topic: Chronic Heart Failure

Session: Heart failure as a major local and global challenge in the 21st century

Thumbnail

Prescription of recommended therapy decreases with the severity of heart failure

Event: HEART FAILURE 2016

Topic: Chronic nursing care

Session: Chronic heart failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb